-
Signature
-
/s/ Michael Brudoley as attorney-in-fact for Mark Pearson
-
Stock symbol
-
EQH
-
Transactions as of
-
Jan 15, 2025
-
Transactions value $
-
-$1,102,101
-
Form type
-
4
-
Date filed
-
1/16/2025, 05:35 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
EQH |
Common Stock |
Options Exercise |
$186K |
+8.73K |
+1.36% |
$21.34 |
649K |
Jan 15, 2025 |
Direct |
F1, F2 |
transaction |
EQH |
Common Stock |
Options Exercise |
$261K |
+11.3K |
+1.74% |
$23.18 |
660K |
Jan 15, 2025 |
Direct |
F1, F2 |
transaction |
EQH |
Common Stock |
Sale |
-$510K |
-9.88K |
-1.5% |
$51.65 |
650K |
Jan 15, 2025 |
Direct |
F1, F2, F3 |
transaction |
EQH |
Common Stock |
Sale |
-$6.4K |
-123 |
-0.02% |
$52.03 |
650K |
Jan 15, 2025 |
Direct |
F1, F2, F4 |
transaction |
EQH |
Common Stock |
Sale |
-$1.03M |
-20K |
-3.08% |
$51.65 |
630K |
Jan 15, 2025 |
Direct |
F1, F2, F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
EQH |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-8.73K |
-1.87% |
$0.00 |
458K |
Jan 15, 2025 |
Common Stock |
8.73K |
$21.34 |
Direct |
F1, F6 |
transaction |
EQH |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-11.3K |
-2.46% |
$0.00 |
446K |
Jan 15, 2025 |
Common Stock |
11.3K |
$23.18 |
Direct |
F1, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: